Contineum Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsSep 14 →InsidersNo open-market buys. 3 insiders sold $1.9M, all 31 sales on a 10b5-1 plan.→HoldersMontanova Capital 12.3%Jupiter Topco 11.8%BlackRock 8.9%→Financing →PeersClosest companies: LONA, VKTX, ORIC→
From the filings
Figures
- Net income
- −$57.6Mlast 12 months
- Operating cash flow
- −$57.2Mlast 12 months
- Cash and equivalents
- $14.7Mat the last balance sheet
- Shares outstanding
- 23.1M shareson issue